Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.

PubWeight™: 16.12‹?› | Rank: Top 0.1% | All-Time Top 10000

🔗 View Article (PMID 19560604)

Published in Lancet on June 27, 2009

Authors

Jürgen Rehm1, Colin Mathers, Svetlana Popova, Montarat Thavorncharoensap, Yot Teerawattananon, Jayadeep Patra

Author Affiliations

1: Public Health and Regulatory Policies, Centre for Addiction and Mental Health, Toronto, ON, Canada. jtrehm@aol.com

Articles citing this

(truncated to the top 100)

Use of mass media campaigns to change health behaviour. Lancet (2010) 6.33

The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction (2010) 5.14

Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology (2011) 5.06

The use of deception in public health behavioral intervention trials: a case study of three online alcohol trials. Am J Bioeth (2013) 4.37

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry (2015) 4.09

Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med (2014) 3.17

Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). BMJ (2010) 2.97

Substance abuse disorders treatment in El Salvador: analysis of policy-making-related failure. Subst Use Misuse (2012) 2.68

Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry (2013) 2.54

Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health (2010) 2.42

The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health (2009) 2.39

Online alcohol interventions: a systematic review. J Med Internet Res (2010) 2.37

The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together. Drug Alcohol Depend (2010) 2.37

Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials. Addiction (2015) 2.36

Effectiveness of E-self-help interventions for curbing adult problem drinking: a meta-analysis. J Med Internet Res (2011) 2.28

Alcohol consumption and cognitive decline in early old age. Neurology (2014) 2.18

Global alcohol producers, science, and policy: the case of the International Center for Alcohol Policies. Am J Public Health (2011) 2.17

A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02

Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry (2011) 2.01

Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A (2011) 2.01

Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis (2014) 1.95

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94

Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction (2011) 1.93

Long-term health benefits of physical activity--a systematic review of longitudinal studies. BMC Public Health (2013) 1.92

Alcohol and mortality in Russia: prospective observational study of 151,000 adults. Lancet (2014) 1.90

Adult consequences of late adolescent alcohol consumption: a systematic review of cohort studies. PLoS Med (2011) 1.89

Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Popul Health Metr (2010) 1.86

Developing an alcohol policy assessment toolkit: application in the western Pacific. Bull World Health Organ (2014) 1.79

Birth cohort effects and gender differences in alcohol epidemiology: a review and synthesis. Alcohol Clin Exp Res (2011) 1.77

Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74

The risks associated with alcohol use and alcoholism. Alcohol Res Health (2011) 1.69

Privacy protection for patients with substance use problems. Subst Abuse Rehabil (2011) 1.64

Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol (2010) 1.64

Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther (2010) 1.62

On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption. PLoS One (2011) 1.61

Combined role of childhood maltreatment, family history, and gender in the risk for alcohol dependence. Psychol Med (2012) 1.61

Industry use of evidence to influence alcohol policy: a case study of submissions to the 2008 Scottish government consultation. PLoS Med (2013) 1.60

Volumetric differences in the anterior cingulate cortex prospectively predict alcohol-related problems in adolescence. Psychopharmacology (Berl) (2014) 1.58

Impact on alcohol purchasing of a ban on multi-buy promotions: a quasi-experimental evaluation comparing Scotland with England and Wales. Addiction (2014) 1.58

Holidays, celebrations, and commiserations: measuring drinking during feasting and fasting to improve national and individual estimates of alcohol consumption. BMC Med (2015) 1.58

Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol (2012) 1.56

Per capita alcohol consumption and ischemic heart disease mortality in a panel of US states from 1950 to 2002. Addiction (2010) 1.56

Minimum alcohol prices and outlet densities in British Columbia, Canada: estimated impacts on alcohol-attributable hospital admissions. Am J Public Health (2013) 1.55

The role of race/ethnicity in alcohol-attributable injury in the United States. Epidemiol Rev (2011) 1.55

Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol (2011) 1.52

Are we reluctant to talk about cultural determinants? Indian J Med Res (2011) 1.51

Living in proximity of a bar and risky alcohol behaviours: a longitudinal study. Addiction (2012) 1.49

Intervention against excessive alcohol consumption in primary health care: a survey of GPs' attitudes and practices in England 10 years on. Alcohol Alcohol (2011) 1.47

A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med (2013) 1.47

Efficacy and the strength of evidence of U.S. alcohol control policies. Am J Prev Med (2013) 1.47

Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health (2013) 1.46

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials. PLoS Med (2015) 1.44

A new scale of the U.S. alcohol policy environment and its relationship to binge drinking. Am J Prev Med (2014) 1.43

Alcoholism risk reduction in France: a modernised approach related to alcohol misuse disorders. Int J Environ Res Public Health (2014) 1.39

Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer (2014) 1.38

Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil (2010) 1.38

Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav (2011) 1.38

Integrating HIV/AIDS and alcohol research. Alcohol Res Health (2010) 1.36

Alcoholic beverage consumption, nutrient intakes, and diet quality in the US adult population, 1999-2006. J Am Diet Assoc (2010) 1.36

Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology (2013) 1.35

Difficulties with telephone-based surveys on alcohol consumption in high-income countries: the Canadian example. Int J Methods Psychiatr Res (2012) 1.34

Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Public Health (2011) 1.32

Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol (2010) 1.32

Alcohol in Canada: reducing the toll through focused interventions and public health policies. CMAJ (2011) 1.31

Integrating information on substance use disorders into electronic health record systems. J Subst Abuse Treat (2011) 1.29

A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come. PLoS Med (2012) 1.28

Life expectancy and disparity: an international comparison of life table data. BMJ Open (2011) 1.27

Effectiveness of guided and unguided low-intensity internet interventions for adult alcohol misuse: a meta-analysis. PLoS One (2014) 1.27

Drinking motives moderate daily relationships between PTSD symptoms and alcohol use. J Abnorm Psychol (2014) 1.24

Acute alcohol intoxication and suicide: a gender-stratified analysis of the National Violent Death Reporting System. Inj Prev (2012) 1.24

Chronic diseases and conditions related to alcohol use. Alcohol Res (2013) 1.24

Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment. Addict Sci Clin Pract (2012) 1.23

U.S. alcohol affordability and real tax rates, 1950-2011. Am J Prev Med (2013) 1.23

The effectiveness of electronic screening and brief intervention for reducing levels of alcohol consumption: a systematic review and meta-analysis. J Med Internet Res (2014) 1.22

Craving to quit: psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions. Psychol Addict Behav (2012) 1.22

Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health (2010) 1.22

Prevalence and correlates of at-risk drinking among older adults: the project SHARE study. J Gen Intern Med (2010) 1.21

Child maltreatment increases sensitivity to adverse social contexts: neighborhood physical disorder and incident binge drinking in Detroit. Drug Alcohol Depend (2011) 1.21

Alcohol screening and brief intervention for adolescents: the how, what and where of reducing alcohol consumption and related harm among young people. Alcohol Alcohol (2013) 1.20

Under the radar: a cross-sectional study of the challenge of identifying at-risk alcohol consumption in the general practice setting. BMC Fam Pract (2014) 1.20

Public health, academic medicine, and the alcohol industry's corporate social responsibility activities. Am J Public Health (2012) 1.20

Implications for alcohol minimum unit pricing advocacy: what can we learn for public health from UK newsprint coverage of key claim-makers in the policy debate? Soc Sci Med (2013) 1.19

Mechanisms and cell signaling in alcoholic liver disease. Biol Chem (2010) 1.19

Shortened telomeres in individuals with abuse in alcohol consumption. Int J Cancer (2011) 1.19

Alcohol consumption in movies and adolescent binge drinking in 6 European countries. Pediatrics (2012) 1.18

New research findings since the 2007 Surgeon General's Call to Action to Prevent and Reduce Underage Drinking: a review. J Stud Alcohol Drugs (2014) 1.18

Alcohol abstinence and drinking among African women: data from the World Health Surveys. BMC Public Health (2011) 1.18

The raising of minimum alcohol prices in Saskatchewan, Canada: impacts on consumption and implications for public health. Am J Public Health (2012) 1.16

Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol (2014) 1.15

Risk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis. EBioMedicine (2015) 1.15

Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005. BMC Public Health (2012) 1.15

Socioeconomic patterning of excess alcohol consumption and binge drinking: a cross-sectional study of multilevel associations with neighbourhood deprivation. BMJ Open (2013) 1.14

Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J Dig Dis (2012) 1.14

Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries. Biochem Res Int (2011) 1.14

Young adults at risk for excess alcohol consumption are often not asked or counseled about drinking alcohol. J Gen Intern Med (2012) 1.13

Modeling the cost-effectiveness of health care systems for alcohol use disorders: how implementation of eHealth interventions improves cost-effectiveness. J Med Internet Res (2011) 1.13

Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med (2014) 1.12

Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res (2013) 1.12

Six rapid assessments of alcohol and other substance use in populations displaced by conflict. Confl Health (2011) 1.11

Framing international trade and chronic disease. Global Health (2011) 1.11

Articles by these authors

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48

Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet (2012) 25.96

Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30

Preventing chronic diseases: how many lives can we save? Lancet (2005) 14.77

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Preventing stroke: saving lives around the world. Lancet Neurol (2007) 6.55

Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80

Violence-related mortality in Iraq from 2002 to 2006. N Engl J Med (2008) 5.43

The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction (2010) 5.14

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet (2012) 4.76

Chronic diseases and injuries in India. Lancet (2011) 4.27

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med (2009) 3.42

Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30

Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care (2009) 3.03

Hours and days of sale and density of alcohol outlets: impacts on alcohol consumption and damage: a systematic review. Alcohol Alcohol (2009) 2.71

50-year mortality trends in children and young people: a study of 50 low-income, middle-income, and high-income countries. Lancet (2011) 2.52

The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health (2009) 2.39

The health of aging populations in China and India. Health Aff (Millwood) (2008) 2.37

Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev (2010) 2.37

HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr (2006) 2.35

Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries. Trop Med Int Health (2014) 2.27

Changes in illicit opioid use across Canada. CMAJ (2006) 2.20

Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol (2007) 2.02

Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for prevention and policy. Addiction (2006) 2.01

Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction (2011) 1.93

Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol (2007) 1.89

Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002. Addiction (2006) 1.79

Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64

Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction (2009) 1.60

Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res (2007) 1.58

WHO and global health monitoring: the way forward. PLoS Med (2010) 1.58

Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction (2006) 1.45

Preventing chronic disease: a priority for global health. Int J Epidemiol (2006) 1.42

Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health (2008) 1.41

Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand. Value Health (2012) 1.35

The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs (2007) 1.30

Maternal deaths drop by one-third from 1990 to 2008: a United Nations analysis. Bull World Health Organ (2010) 1.27

Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics (2009) 1.23

Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res (2006) 1.21

Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Res Treat (2011) 1.20

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment. BMC Health Serv Res (2010) 1.18

The economic impact of alcohol consumption: a systematic review. Subst Abuse Treat Prev Policy (2009) 1.17

Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005. BMC Public Health (2012) 1.15

Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health (2009) 1.14

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand. BMC Health Serv Res (2010) 1.12

Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One (2012) 1.11

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. Pharmacoeconomics (2011) 1.11

The quality of alcohol products in Vietnam and its implications for public health. Int J Environ Res Public Health (2009) 1.09

Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res (2010) 1.08

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia (2013) 1.07

Universal coverage and its impact on reproductive health services in Thailand. Reprod Health Matters (2002) 1.07

Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ (2013) 1.06

Using economic evaluation in policy decision-making in Asian countries: mission impossible or mission probable? Value Health (2010) 1.06

Prevalence of fetal alcohol spectrum disorders in child care settings: a meta-analysis. Pediatrics (2013) 1.05

Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users. Drug Alcohol Rev (2008) 1.05

Global health risks: progress and challenges. Bull World Health Organ (2009) 1.04

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand. Health Res Policy Syst (2012) 1.04

Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS One (2012) 1.02

Determination of lifetime injury mortality risk in Canada in 2002 by drinking amount per occasion and number of occasions. Am J Epidemiol (2008) 1.01

Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. Int J Cancer (2007) 1.01

Alcohol-attributable burden of disease and injury in Canada, 2004. Int J Public Health (2011) 1.00

How many people in Canada use prescription opioids non-medically in general and street drug using populations? Can J Public Health (2009) 0.99

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. BMC Public Health (2010) 0.99

Estimating chronic disease deaths and hospitalizations due to alcohol use in Canada in 2002: implications for policy and prevention strategies. Prev Chronic Dis (2006) 0.98

Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health (2008) 0.98

Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can (2007) 0.97

Using health technology assessment for informing coverage decisions in Thailand. J Comp Eff Res (2012) 0.97

Impact of the introduction of government use licenses on the drug expenditure on seven medicines in Thailand. Value Health (2012) 0.97

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res (2010) 0.94

Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption. Popul Health Metr (2012) 0.93

Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol (2012) 0.92

Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: recommendations for policy and prevention. J Stud Alcohol Drugs (2007) 0.91

Social values and health policy: a new international research programme. J Health Organ Manag (2012) 0.90

Government use licenses in Thailand: an assessment of the health and economic impacts. Global Health (2011) 0.90

Alcohol consumption and alcohol-attributable burden of disease in Switzerland, 2002. Int J Public Health (2007) 0.89

Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health (2013) 0.89

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand. BMC Public Health (2011) 0.87

Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN). J Subst Abuse Treat (2007) 0.87

Different guidelines for different countries? On the scientific basis of low-risk drinking guidelines and their implications. Drug Alcohol Rev (2011) 0.87

Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period. Can J Public Health (2007) 0.86

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context? Vaccine (2013) 0.86

Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatr Res (2010) 0.86

Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy (2007) 0.86

Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002. BMC Public Health (2007) 0.86